Latest & greatest articles for atrial fibrillation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on atrial fibrillation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on atrial fibrillation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for atrial fibrillation

781. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.

Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. BACKGROUND: In-hospital administration of flecainide and propafenone in a single oral loading dose has been shown to be effective and superior to placebo in terminating atrial fibrillation. We evaluated the feasibility and the safety of self-administered oral loading of flecainide and propafenone in terminating atrial fibrillation of recent onset outside the hospital. METHODS: We administered either (...) flecainide or propafenone orally to restore sinus rhythm in 268 patients with mild heart disease or none who came to the emergency room with atrial fibrillation of recent onset that was hemodynamically well tolerated. Of these patients, 58 (22 percent) were excluded from the study because of treatment failure or side effects. Out-of-hospital self-administration of flecainide or propafenone--the "pill-in-the-pocket" approach--after the onset of heart palpitations was evaluated in the remaining 210

NEJM2004

782. Obesity and the risk of new-onset atrial fibrillation.

Obesity and the risk of new-onset atrial fibrillation. CONTEXT: Obesity is associated with atrial enlargement and ventricular diastolic dysfunction, both known predictors of atrial fibrillation (AF). However, it is unclear whether obesity is a risk factor for AF. OBJECTIVE: To examine the association between body mass index (BMI) and the risk of developing AF. DESIGN, SETTING, AND PARTICIPANTS: Prospective, community-based observational cohort in Framingham, Mass. We studied 5282 participants (...) (mean age, 57 [SD, 13] years; 2898 women [55%]) without baseline AF (electrocardiographic AF or arterial flutter). Body mass index (calculated as weight in kilograms divided by square of height in meters) was evaluated as both a continuous and a categorical variable (normal defined as <25.0; overweight, 25.0 to <30.0; and obese, > or =30.0). In addition to adjusting for clinical confounders by multivariable techniques, we also examined models including echocardiographic left atrial diameter

JAMA2004

783. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. BACKGROUND: The risk for atrial fibrillation-associated stroke increases at low anticoagulation intensities. However, higher intensities increase hemorrhage risk. Optimal use of warfarin for atrial fibrillation requires precise information on the risk for intracranial hemorrhage as a function of patient age and anticoagulation intensity. OBJECTIVE: To examine (...) the relationship of age, anticoagulation intensity, and risk for intracranial hemorrhage. DESIGN: Case-control study. SETTING: Academic medical center. PATIENTS: 170 case-patients who developed intracranial hemorrhage during warfarin therapy and 1020 matched controls who did not; both case-patients and controls were taking warfarin for atrial fibrillation. MEASUREMENTS: The authors performed multivariable conditional logistic regression to determine the odds of intracranial hemorrhage with regard to age

Annals of Internal Medicine2004

784. Cost-effectiveness of rhythm versus rate control in atrial fibrillation.

Cost-effectiveness of rhythm versus rate control in atrial fibrillation. BACKGROUND: Atrial fibrillation is the most common type of sustained cardiac arrhythmia, but recent trials have identified no clear advantage of rhythm control over rate control. Consequently, economic factors often play a role in guiding treatment selection. OBJECTIVE: To estimate the cost-effectiveness of rhythm-control versus rate-control strategies for atrial fibrillation in the Atrial Fibrillation Follow-up (...) Investigation of Rhythm Management (AFFIRM). DESIGN: Retrospective economic evaluation. Nonparametric bootstrapping was used to estimate the distribution of incremental costs and effects on the cost-effectiveness plane. DATA SOURCES: Data on survival and use of health care resources were obtained for all 4060 AFFIRM participants. Unit costs were estimated from various U.S. databases. TARGET POPULATION: Patients with atrial fibrillation who were 65 years of age or who had other risk factors for stroke or

Annals of Internal Medicine2004

785. Is there a role for maintaining sinus rhythm in patients with atrial fibrillation?

Is there a role for maintaining sinus rhythm in patients with atrial fibrillation? Recent studies have indicated that outcomes in patients with atrial fibrillation who are managed with rate control and anticoagulation are similar to those in patients who have maintenance of sinus rhythm. These studies did not include important groups of patients with atrial fibrillation in whom antiarrhythmic therapy may be appropriate. This perspective argues for the maintenance of sinus rhythm and for the use

Annals of Internal Medicine2004

786. Rate control was not inferior to rhythm control for recurrent persistent atrial fibrillation

Rate control was not inferior to rhythm control for recurrent persistent atrial fibrillation Rate control was not inferior to rhythm control for recurrent persistent atrial fibrillation | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search (...) for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Rate control was not inferior to rhythm control for recurrent persistent atrial fibrillation Article Text Therapeutics Rate control was not inferior to rhythm control for recurrent persistent atrial fibrillation Free Alan Silver , MD, MPH Statistics from Altmetric.com No Altmetric data available for this article. ( 2002 ) N

Evidence-Based Medicine (Requires free registration)2004

787. Rhythm control strategies were not better than rate control strategies for atrial fibrillation

Rhythm control strategies were not better than rate control strategies for atrial fibrillation Rhythm control strategies were not better than rate control strategies for atrial fibrillation | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search (...) for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Rhythm control strategies were not better than rate control strategies for atrial fibrillation Article Text Therapeutics Rhythm control strategies were not better than rate control strategies for atrial fibrillation Free Alan Silver , MD, MPH Statistics from Altmetric.com No Altmetric data available for this article. ( 2002

Evidence-Based Medicine (Requires free registration)2004

788. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring.

Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. CONTEXT: Atrial fibrillation (AF) is the most common cardiac dysrhythmia in the United States. Whereas rare cases of familial AF have been reported, it is unknown if AF among unselected individuals is a heritable condition. OBJECTIVE: To determine whether parental AF increases the risk for the development of offspring AF. DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort study (1983-2002) within (...) the Framingham Heart Study, a population-based epidemiologic study. Participants were 2243 offspring (1165 women, 1078 men) at least 30 years of age and free of AF whose parents had both been evaluated in the original cohort. MAIN OUTCOME MEASURES: Development of new-onset AF in the offspring was prospectively examined in association with previously documented parental AF. RESULTS: Among 2243 offspring participants, 681 (30%) had at least 1 parent with documented AF; 70 offspring participants (23 women; mean

JAMA2004

789. A multicenter risk index for atrial fibrillation after cardiac surgery.

A multicenter risk index for atrial fibrillation after cardiac surgery. CONTEXT: Atrial fibrillation is a common, but potentially preventable, complication following coronary artery bypass graft (CABG) surgery. OBJECTIVES: To assess the nature and consequences of atrial fibrillation after CABG surgery and to develop a comprehensive risk index that can better identify patients at risk for atrial fibrillation. DESIGN, SETTING, AND PARTICIPANTS: Prospective observational study of 4657 patients (...) undergoing CABG surgery between November 1996 and June 2000 at 70 centers located within 17 countries, selected using a systematic sampling technique. From a derivation cohort of 3093 patients, associations between predictor variables and postoperative atrial fibrillation were identified to develop a risk model, which was assessed in a validation cohort of 1564 patients. MAIN OUTCOME MEASURE: New-onset atrial fibrillation after CABG surgery. RESULTS: A total of 1503 patients (32.3%) developed

JAMA2004

790. Systematic review of intraoperative ablation for the treatment of atrial fibrillation

Systematic review of intraoperative ablation for the treatment of atrial fibrillation Systematic review of intraoperative ablation for the treatment of atrial fibrillation Systematic review of intraoperative ablation for the treatment of atrial fibrillation Hazel S J, et al CRD summary This review assessed the efficacy and safety of intra-operative surgical ablation in the treatment of atrial fibrillation. The authors concluded that intra-operative ablation is at least as effective as surgery (...) alone or the Maze-III procedure. The lack of evidence from randomised controlled trials and the poor quality of the available evidence justify the limited conclusions; however, some of the review methods were unclear. Authors' objectives To assess the safety and efficacy of intra-operative ablation techniques for the treatment of atrial fibrillation (AF). Searching MEDLINE, EMBASE, the Cochrane Library, the Science Citation Index, ClinicalTrials.gov, the NHS Centre for Reviews and Dissemination

DARE.2004

791. A systematic review of intraoperative ablation for the treatment of atrial fibrillation

A systematic review of intraoperative ablation for the treatment of atrial fibrillation A systematic review of intraoperative ablation for the treatment of atrial fibrillation A systematic review of intraoperative ablation for the treatment of atrial fibrillation Hazel S J Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Hazel S J (...) . A systematic review of intraoperative ablation for the treatment of atrial fibrillation. Stepney, SA: Australian Safety and Efficacy Register of New Interventional Procedures - Surgical (ASERNIP-S) 2004: 388 Authors' objectives The aim of this review was to assess the safety and efficacy of intraoperative surgical ablation techniques for the treatment of atrial fibrillation (AF) compared to other surgical procedures, including cardiac surgery (CS) alone, or the Maze-III procedure, the current gold standard

Health Technology Assessment (HTA) Database.2004

792. The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials

The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials The role of angiotensin receptor blockers (...) and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials Madrid A H, Peng J, Zamora J, Marin I, Bernal E, Escobar C, Munos-Tinoco C, Rebollo J M, Moro C CRD summary This review assessed the effects of angiotensin II type-1 receptor blockers and/or angiotensin-converting enzyme inhibitors in the prevention of atrial fibrillation. The authors concluded that treatment with these drugs

DARE.2004

793. Low-dose warfarin in atrial fibrillation leads to more thromboembolic events without reducing major bleeding when compared to adjusted-dose: a meta-analysis

Low-dose warfarin in atrial fibrillation leads to more thromboembolic events without reducing major bleeding when compared to adjusted-dose: a meta-analysis Low-dose warfarin in atrial fibrillation leads to more thromboembolic events without reducing major bleeding when compared to adjusted-dose: a meta-analysis Low-dose warfarin in atrial fibrillation leads to more thromboembolic events without reducing major bleeding when compared to adjusted-dose: a meta-analysis Perret-Guillaume C, Wahl D G (...) CRD summary This review looked at the effects of low- or mini-dose warfarin, compared with a regimen where the warfarin dose was adjusted to a target International Normalised Ratio (INR), in people with non-rheumatic atrial fibrillation. The risk of thromboembolic events was higher with low- or mini-dose warfarin. The review appears to have been well conducted and the conclusions are supported by the data presented. Authors' objectives To assess the effects of reduced-dose (low-dose or mini-dose

DARE.2004

794. Atrial pacing for the prevention of atrial fibrillation after coronary artery bypass graft surgery: a review of the literature

Atrial pacing for the prevention of atrial fibrillation after coronary artery bypass graft surgery: a review of the literature Atrial pacing for the prevention of atrial fibrillation after coronary artery bypass graft surgery: a review of the literature Atrial pacing for the prevention of atrial fibrillation after coronary artery bypass graft surgery: a review of the literature Archbold R A, Schilling R J CRD summary This review attempted to assess the use of pacing to prevent irregular heart (...) rhythms after coronary bypass surgery. The authors concluded that biatrial pacing was effective, but that there is insufficient evidence pertaining to single atrial pacing. Methodological weaknesses and poor reporting of the review process mean that the conclusions should be treated with caution. Authors' objectives To critically review the trial evidence regarding the efficacy of epicardial atrial pacing (AP) to prevent post coronary artery bypass graft (CABG) atrial fibrillation (AF). Searching

DARE.2004

795. The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis

The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis Gerson L B, Triadafilopoulos G, Gage B F Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Seven strategies for the management of anticoagulants in the periendoscopic period for patients with atrial fibrillation were investigated. The strategies were as follows. Continue warfarin: a colonoscopy was performed without interrupting warfarin therapy. Hold warfarin

NHS Economic Evaluation Database.2004

796. Cost effectiveness of ibutilide with prophylactic magnesium in the treatment of atrial fibrillation

Cost effectiveness of ibutilide with prophylactic magnesium in the treatment of atrial fibrillation Cost effectiveness of ibutilide with prophylactic magnesium in the treatment of atrial fibrillation Cost effectiveness of ibutilide with prophylactic magnesium in the treatment of atrial fibrillation Coleman C I, Kalus J S, White C M, Spencer A P, Tsikouris J P, Chung J O, Kenyon K W, Ziska M, Kluger J, Reddy P Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study compared the use of ibutilide in the presence and absence of magnesium prophylaxis for the conversion of atrial fibrillation (AF). The mean dose of ibutilide was 2.2 (+/- 1) g. Type of intervention Treatment. Economic study type Cost-effectiveness analysis

NHS Economic Evaluation Database.2004

797. Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery

Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery Reddy P, Kalus J S, Caron M F, Horowitz (...) S, Karapanos A, Coleman CI, Kluger J, White C M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Four alternative prophylactic strategies for preventing atrial fibrillation (AF) in patients undergoing open heart surgery were

NHS Economic Evaluation Database.2004

798. Cost-effectiveness of rhythm versus rate control in atrial fibrillation

Cost-effectiveness of rhythm versus rate control in atrial fibrillation Cost-effectiveness of rhythm versus rate control in atrial fibrillation Cost-effectiveness of rhythm versus rate control in atrial fibrillation Marshall D A, Levy A R, Vidaillet H, Fenwick E, Slee A, Blackhouse G, Greene H L, Wyse D G, Nichol G, O'Brien B J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology This study considered the treatment of atrial fibrillation (AF) using rhythm versus rate control. Rhythm control was defined as electrical cardioversion, anti-arrhythmic drugs and nonpharmacologic therapies (e.g. multisite atrial pacing, maze procedures or radiofrequency ablation procedures) to maintain sinus rhythm. Rate control used

NHS Economic Evaluation Database.2004

799. Warfarin in the secondary prevention of thromboembolsim in atrial fibrillation: impact of bioavailability on costs and outcomes

Warfarin in the secondary prevention of thromboembolsim in atrial fibrillation: impact of bioavailability on costs and outcomes Warfarin in the secondary prevention of thromboembolsim in atrial fibrillation: impact of bioavailability on costs and outcomes Warfarin in the secondary prevention of thromboembolsim in atrial fibrillation: impact of bioavailability on costs and outcomes Mittmann N, Oh P I, Walker S E, Bartle W R Record Status This is a critical abstract of an economic evaluation (...) that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Several warfarin products with different bioavailability (F) for the prevention of thromboembolism in atrial fibrillation were examined. Strategy 1 was warfarin with F=1 (brand warfarin). Strategy 2 was warfarin with F=0.80. Strategy 3 was warfarin with F

NHS Economic Evaluation Database.2004

800. Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan

Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan Maeda K, Shimbo T, Fukui T Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology An annual electrocardiogram (ECG) community-based screening programme and an annual pulse palpation community-based screening programme for chronic atrial fibrillation (AF) were compared with no screening. Different screening intervals and starting ages (65 or 75 years) were also evaluated. Type of intervention Screening. Economic study type Cost

NHS Economic Evaluation Database.2004